Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.

The global Animal Antibacterial Peptide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 177%.

This report aims to provide a comprehensive presentation of the global market for Animal Antibacterial Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Antibacterial Peptide.

Report Scope

The Animal Antibacterial Peptide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Antibacterial Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Animal Antibacterial Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Animal Antibacterial Peptide Market Report

Report Metric	Details
Report Name	Animal Antibacterial Peptide Market
Accounted market size in 2021	$ 38.3 billion
Base Year	2021
Segment by Type	Anionic Peptides Cationic Peptide
Segment by Application	Poultry Livestock
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics, Boehringer Ingelheim Vetmedica
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Antibacterial Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the Animal Antibacterial Peptide Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Animal Antibacterial Peptide Market report?

Ans: The main players in the Animal Antibacterial Peptide Market are Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics, Boehringer Ingelheim Vetmedica

What are the Application segmentation covered in the Animal Antibacterial Peptide Market report?

Ans: The Applications covered in the Animal Antibacterial Peptide Market report are Poultry, Livestock

What are the Type segmentation covered in the Animal Antibacterial Peptide Market report?

Ans: The Types covered in the Animal Antibacterial Peptide Market report are Anionic Peptides, Cationic Peptide

1 Animal Antibacterial Peptide Market Overview

1.1 Product Overview and Scope of Animal Antibacterial Peptide

1.2 Animal Antibacterial Peptide Segment by Type

1.2.1 Global Animal Antibacterial Peptide Market Value Comparison by Type (2024-2030)

1.2.2 Anionic Peptides

1.2.3 Cationic Peptide

1.3 Animal Antibacterial Peptide Segment by Application

1.3.1 Global Animal Antibacterial Peptide Market Value by Application: (2024-2030)

1.3.2 Poultry

1.3.3 Livestock

1.4 Global Animal Antibacterial Peptide Market Size Estimates and Forecasts

1.4.1 Global Animal Antibacterial Peptide Revenue 2019-2030

1.4.2 Global Animal Antibacterial Peptide Sales 2019-2030

1.4.3 Global Animal Antibacterial Peptide Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Animal Antibacterial Peptide Market Competition by Manufacturers

2.1 Global Animal Antibacterial Peptide Sales Market Share by Manufacturers (2019-2024)

2.2 Global Animal Antibacterial Peptide Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Animal Antibacterial Peptide Average Price by Manufacturers (2019-2024)

2.4 Global Animal Antibacterial Peptide Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Animal Antibacterial Peptide, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Animal Antibacterial Peptide, Product Type & Application

2.7 Animal Antibacterial Peptide Market Competitive Situation and Trends

2.7.1 Animal Antibacterial Peptide Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Animal Antibacterial Peptide Players Market Share by Revenue

2.7.3 Global Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Animal Antibacterial Peptide Retrospective Market Scenario by Region

3.1 Global Animal Antibacterial Peptide Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Animal Antibacterial Peptide Global Animal Antibacterial Peptide Sales by Region: 2019-2030

3.2.1 Global Animal Antibacterial Peptide Sales by Region: 2019-2024

3.2.2 Global Animal Antibacterial Peptide Sales by Region: 2025-2030

3.3 Global Animal Antibacterial Peptide Global Animal Antibacterial Peptide Revenue by Region: 2019-2030

3.3.1 Global Animal Antibacterial Peptide Revenue by Region: 2019-2024

3.3.2 Global Animal Antibacterial Peptide Revenue by Region: 2025-2030

3.4 North America Animal Antibacterial Peptide Market Facts & Figures by Country

3.4.1 North America Animal Antibacterial Peptide Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Animal Antibacterial Peptide Sales by Country (2019-2030)

3.4.3 North America Animal Antibacterial Peptide Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Animal Antibacterial Peptide Market Facts & Figures by Country

3.5.1 Europe Animal Antibacterial Peptide Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Animal Antibacterial Peptide Sales by Country (2019-2030)

3.5.3 Europe Animal Antibacterial Peptide Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Animal Antibacterial Peptide Market Facts & Figures by Country

3.6.1 Asia Pacific Animal Antibacterial Peptide Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Animal Antibacterial Peptide Sales by Country (2019-2030)

3.6.3 Asia Pacific Animal Antibacterial Peptide Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Animal Antibacterial Peptide Market Facts & Figures by Country

3.7.1 Latin America Animal Antibacterial Peptide Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Animal Antibacterial Peptide Sales by Country (2019-2030)

3.7.3 Latin America Animal Antibacterial Peptide Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Animal Antibacterial Peptide Market Facts & Figures by Country

3.8.1 Middle East and Africa Animal Antibacterial Peptide Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Animal Antibacterial Peptide Sales by Country (2019-2030)

3.8.3 Middle East and Africa Animal Antibacterial Peptide Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Animal Antibacterial Peptide Sales by Type (2019-2030)

4.1.1 Global Animal Antibacterial Peptide Sales by Type (2019-2024)

4.1.2 Global Animal Antibacterial Peptide Sales by Type (2025-2030)

4.1.3 Global Animal Antibacterial Peptide Sales Market Share by Type (2019-2030)

4.2 Global Animal Antibacterial Peptide Revenue by Type (2019-2030)

4.2.1 Global Animal Antibacterial Peptide Revenue by Type (2019-2024)

4.2.2 Global Animal Antibacterial Peptide Revenue by Type (2025-2030)

4.2.3 Global Animal Antibacterial Peptide Revenue Market Share by Type (2019-2030)

4.3 Global Animal Antibacterial Peptide Price by Type (2019-2030)

5 Segment by Application

5.1 Global Animal Antibacterial Peptide Sales by Application (2019-2030)

5.1.1 Global Animal Antibacterial Peptide Sales by Application (2019-2024)

5.1.2 Global Animal Antibacterial Peptide Sales by Application (2025-2030)

5.1.3 Global Animal Antibacterial Peptide Sales Market Share by Application (2019-2030)

5.2 Global Animal Antibacterial Peptide Revenue by Application (2019-2030)

5.2.1 Global Animal Antibacterial Peptide Revenue by Application (2019-2024)

5.2.2 Global Animal Antibacterial Peptide Revenue by Application (2025-2030)

5.2.3 Global Animal Antibacterial Peptide Revenue Market Share by Application (2019-2030)

5.3 Global Animal Antibacterial Peptide Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merial

6.1.1 Merial Corporation Information

6.1.2 Merial Description and Business Overview

6.1.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merial Animal Antibacterial Peptide Product Portfolio

6.1.5 Merial Recent Developments/Updates

6.2 Zoetis

6.2.1 Zoetis Corporation Information

6.2.2 Zoetis Description and Business Overview

6.2.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Zoetis Animal Antibacterial Peptide Product Portfolio

6.2.5 Zoetis Recent Developments/Updates

6.3 Bayer HealthCare

6.3.1 Bayer HealthCare Corporation Information

6.3.2 Bayer HealthCare Description and Business Overview

6.3.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bayer HealthCare Animal Antibacterial Peptide Product Portfolio

6.3.5 Bayer HealthCare Recent Developments/Updates

6.4 Merck Animal Health

6.4.1 Merck Animal Health Corporation Information

6.4.2 Merck Animal Health Description and Business Overview

6.4.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Animal Health Animal Antibacterial Peptide Product Portfolio

6.4.5 Merck Animal Health Recent Developments/Updates

6.5 Elanco (Eli Lilly and Company)

6.5.1 Elanco (Eli Lilly and Company) Corporation Information

6.5.2 Elanco (Eli Lilly and Company) Description and Business Overview

6.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Portfolio

6.5.5 Elanco (Eli Lilly and Company) Recent Developments/Updates

6.6 Biogenesis Bago

6.6.1 Biogenesis Bago Corporation Information

6.6.2 Biogenesis Bago Description and Business Overview

6.6.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Biogenesis Bago Animal Antibacterial Peptide Product Portfolio

6.6.5 Biogenesis Bago Recent Developments/Updates

6.7 Animal Medics

6.6.1 Animal Medics Corporation Information

6.6.2 Animal Medics Description and Business Overview

6.6.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Animal Medics Animal Antibacterial Peptide Product Portfolio

6.7.5 Animal Medics Recent Developments/Updates

6.8 Boehringer Ingelheim Vetmedica

6.8.1 Boehringer Ingelheim Vetmedica Corporation Information

6.8.2 Boehringer Ingelheim Vetmedica Description and Business Overview

6.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Portfolio

6.8.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Animal Antibacterial Peptide Industry Chain Analysis

7.2 Animal Antibacterial Peptide Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Animal Antibacterial Peptide Production Mode & Process

7.4 Animal Antibacterial Peptide Sales and Marketing

7.4.1 Animal Antibacterial Peptide Sales Channels

7.4.2 Animal Antibacterial Peptide Distributors

7.5 Animal Antibacterial Peptide Customers

8 Animal Antibacterial Peptide Market Dynamics

8.1 Animal Antibacterial Peptide Industry Trends

8.2 Animal Antibacterial Peptide Market Drivers

8.3 Animal Antibacterial Peptide Market Challenges

8.4 Animal Antibacterial Peptide Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Elanco (Eli Lilly and Company)

Biogenesis Bago

Animal Medics

Boehringer Ingelheim Vetmedica

List of Tables

Table 1. Global Animal Antibacterial Peptide Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Animal Antibacterial Peptide Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Animal Antibacterial Peptide Market Competitive Situation by Manufacturers in 2023

Table 4. Global Animal Antibacterial Peptide Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Animal Antibacterial Peptide Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Animal Antibacterial Peptide Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Animal Antibacterial Peptide Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Animal Antibacterial Peptide Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Animal Antibacterial Peptide, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Animal Antibacterial Peptide, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Animal Antibacterial Peptide, Product Type & Application

Table 12. Global Key Manufacturers of Animal Antibacterial Peptide, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Animal Antibacterial Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial Peptide as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Animal Antibacterial Peptide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Animal Antibacterial Peptide Sales by Region (2019-2024) & (K MT)

Table 18. Global Animal Antibacterial Peptide Sales Market Share by Region (2019-2024)

Table 19. Global Animal Antibacterial Peptide Sales by Region (2025-2030) & (K MT)

Table 20. Global Animal Antibacterial Peptide Sales Market Share by Region (2025-2030)

Table 21. Global Animal Antibacterial Peptide Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Animal Antibacterial Peptide Revenue Market Share by Region (2019-2024)

Table 23. Global Animal Antibacterial Peptide Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Animal Antibacterial Peptide Revenue Market Share by Region (2025-2030)

Table 25. North America Animal Antibacterial Peptide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Animal Antibacterial Peptide Sales by Country (2019-2024) & (K MT)

Table 27. North America Animal Antibacterial Peptide Sales by Country (2025-2030) & (K MT)

Table 28. North America Animal Antibacterial Peptide Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Animal Antibacterial Peptide Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Animal Antibacterial Peptide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Animal Antibacterial Peptide Sales by Country (2019-2024) & (K MT)

Table 32. Europe Animal Antibacterial Peptide Sales by Country (2025-2030) & (K MT)

Table 33. Europe Animal Antibacterial Peptide Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Animal Antibacterial Peptide Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Animal Antibacterial Peptide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Animal Antibacterial Peptide Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Animal Antibacterial Peptide Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Animal Antibacterial Peptide Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Animal Antibacterial Peptide Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Animal Antibacterial Peptide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Animal Antibacterial Peptide Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Animal Antibacterial Peptide Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Animal Antibacterial Peptide Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Animal Antibacterial Peptide Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Animal Antibacterial Peptide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Animal Antibacterial Peptide Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Animal Antibacterial Peptide Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Animal Antibacterial Peptide Sales (K MT) by Type (2019-2024)

Table 51. Global Animal Antibacterial Peptide Sales (K MT) by Type (2025-2030)

Table 52. Global Animal Antibacterial Peptide Sales Market Share by Type (2019-2024)

Table 53. Global Animal Antibacterial Peptide Sales Market Share by Type (2025-2030)

Table 54. Global Animal Antibacterial Peptide Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Animal Antibacterial Peptide Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Animal Antibacterial Peptide Revenue Market Share by Type (2019-2024)

Table 57. Global Animal Antibacterial Peptide Revenue Market Share by Type (2025-2030)

Table 58. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2019-2024)

Table 59. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2025-2030)

Table 60. Global Animal Antibacterial Peptide Sales (K MT) by Application (2019-2024)

Table 61. Global Animal Antibacterial Peptide Sales (K MT) by Application (2025-2030)

Table 62. Global Animal Antibacterial Peptide Sales Market Share by Application (2019-2024)

Table 63. Global Animal Antibacterial Peptide Sales Market Share by Application (2025-2030)

Table 64. Global Animal Antibacterial Peptide Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Animal Antibacterial Peptide Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Animal Antibacterial Peptide Revenue Market Share by Application (2019-2024)

Table 67. Global Animal Antibacterial Peptide Revenue Market Share by Application (2025-2030)

Table 68. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2019-2024)

Table 69. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2025-2030)

Table 70. Merial Corporation Information

Table 71. Merial Description and Business Overview

Table 72. Merial Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. Merial Animal Antibacterial Peptide Product

Table 74. Merial Recent Developments/Updates

Table 75. Zoetis Corporation Information

Table 76. Zoetis Description and Business Overview

Table 77. Zoetis Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Zoetis Animal Antibacterial Peptide Product

Table 79. Zoetis Recent Developments/Updates

Table 80. Bayer HealthCare Corporation Information

Table 81. Bayer HealthCare Description and Business Overview

Table 82. Bayer HealthCare Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Bayer HealthCare Animal Antibacterial Peptide Product

Table 84. Bayer HealthCare Recent Developments/Updates

Table 85. Merck Animal Health Corporation Information

Table 86. Merck Animal Health Description and Business Overview

Table 87. Merck Animal Health Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Merck Animal Health Animal Antibacterial Peptide Product

Table 89. Merck Animal Health Recent Developments/Updates

Table 90. Elanco (Eli Lilly and Company) Corporation Information

Table 91. Elanco (Eli Lilly and Company) Description and Business Overview

Table 92. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product

Table 94. Elanco (Eli Lilly and Company) Recent Developments/Updates

Table 95. Biogenesis Bago Corporation Information

Table 96. Biogenesis Bago Description and Business Overview

Table 97. Biogenesis Bago Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Biogenesis Bago Animal Antibacterial Peptide Product

Table 99. Biogenesis Bago Recent Developments/Updates

Table 100. Animal Medics Corporation Information

Table 101. Animal Medics Description and Business Overview

Table 102. Animal Medics Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Animal Medics Animal Antibacterial Peptide Product

Table 104. Animal Medics Recent Developments/Updates

Table 105. Boehringer Ingelheim Vetmedica Corporation Information

Table 106. Boehringer Ingelheim Vetmedica Description and Business Overview

Table 107. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product

Table 109. Boehringer Ingelheim Vetmedica Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Animal Antibacterial Peptide Distributors List

Table 113. Animal Antibacterial Peptide Customers List

Table 114. Animal Antibacterial Peptide Market Trends

Table 115. Animal Antibacterial Peptide Market Drivers

Table 116. Animal Antibacterial Peptide Market Challenges

Table 117. Animal Antibacterial Peptide Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Animal Antibacterial Peptide

Figure 2. Global Animal Antibacterial Peptide Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Animal Antibacterial Peptide Market Share by Type in 2023 & 2030

Figure 4. Anionic Peptides Product Picture

Figure 5. Cationic Peptide Product Picture

Figure 6. Global Animal Antibacterial Peptide Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Animal Antibacterial Peptide Market Share by Application in 2023 & 2030

Figure 8. Poultry

Figure 9. Livestock

Figure 10. Global Animal Antibacterial Peptide Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Animal Antibacterial Peptide Market Size (2019-2030) & (US$ Million)

Figure 12. Global Animal Antibacterial Peptide Sales (2019-2030) & (K MT)

Figure 13. Global Animal Antibacterial Peptide Average Price (USD/MT) & (2019-2030)

Figure 14. Animal Antibacterial Peptide Report Years Considered

Figure 15. Animal Antibacterial Peptide Sales Share by Manufacturers in 2023

Figure 16. Global Animal Antibacterial Peptide Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Animal Antibacterial Peptide Players: Market Share by Revenue in 2023

Figure 18. Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Animal Antibacterial Peptide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Animal Antibacterial Peptide Sales Market Share by Country (2019-2030)

Figure 21. North America Animal Antibacterial Peptide Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Animal Antibacterial Peptide Sales Market Share by Country (2019-2030)

Figure 25. Europe Animal Antibacterial Peptide Revenue Market Share by Country (2019-2030)

Figure 26. Germany Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Animal Antibacterial Peptide Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Animal Antibacterial Peptide Revenue Market Share by Region (2019-2030)

Figure 33. China Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Animal Antibacterial Peptide Sales Market Share by Country (2019-2030)

Figure 44. Latin America Animal Antibacterial Peptide Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Animal Antibacterial Peptide Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Animal Antibacterial Peptide Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. U.A.E Animal Antibacterial Peptide Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Animal Antibacterial Peptide by Type (2019-2030)

Figure 54. Global Revenue Market Share of Animal Antibacterial Peptide by Type (2019-2030)

Figure 55. Global Animal Antibacterial Peptide Price (USD/MT) by Type (2019-2030)

Figure 56. Global Sales Market Share of Animal Antibacterial Peptide by Application (2019-2030)

Figure 57. Global Revenue Market Share of Animal Antibacterial Peptide by Application (2019-2030)

Figure 58. Global Animal Antibacterial Peptide Price (USD/MT) by Application (2019-2030)

Figure 59. Animal Antibacterial Peptide Value Chain

Figure 60. Animal Antibacterial Peptide Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions